AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Clinical trial NCT05678933 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05678933
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma Targeted Therapy

Start date: 2023-01-01
Primary completion: 2027-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.